Safety of aromatase inhibitors in the adjuvant setting

Por Perez, Edith A.
Publicado em 2007

Safety of aromatase inhibitors in the adjuvant setting

Por Perez, Edith A.
Publicado no Breast Cancer Res Treat (2007)

How relevant is hormone receptor status in the context of outcome to HER2-positive breast cancer?

Por Norton, Nadine, Perez, Edith A
Publicado em 2013

Managing the Early and Locally Advanced Breast Cancer Patient at High Risk for Recurrence: Recent Advances and Nursing Implications

Por Palmieri, Frances M., Perez, Edith A.
Publicado em 2007

Treatment Options for Breast Cancer Resistant to Anthracycline and Taxane

Por Moreno-Aspitia, Alvaro, Perez, Edith A.
Publicado em 2009

Treatment options for patients with triple-negative breast cancer

Por Santana-Davila, Rafael, Perez, Edith A
Publicado em 2010

Utility of Tissue Culture for Detection of Toxoplasma gondii in Vitreous Humor of Patients Diagnosed with Toxoplasmic Retinochoroiditis

Por Miller, Darlene, Davis, Janet, Rosa, Robert, Diaz, Martha, Perez, Edith
Publicado em 2000

Aromatase Inhibitors and Bone Loss

Por PEREZ, EDITH A., M., Serene, Durling, Frances C., WEILBAECHER, KATHERINE
Publicado em 2006

Acute stress impairs the retrieval of extinction memory in humans

Por Raio, Candace M., Brignoni-Perez, Edith, Goldman, Rachel, Phelps, Elizabeth A.
Publicado em 2014

Age-Related Disparity in Immediate Prognosis of Patients with Triple-Negative Breast Cancer: A Population-Based Study from SEER Cancer Registries

Por Zhu, Wenjie, Perez, Edith A., Hong, Ruoxi, Li, Qing, Xu, Binghe
Publicado no PLoS One (2015)

Adjuvant Therapy of Triple Negative Breast Cancer

Por Perez, Edith A., Moreno-Aspitia, Alvaro, Thompson, E. Aubrey, Andorfer, Cathy A.
Publicado em 2010

Clima organizacional en profesores investigadores de una institución de educación superior

Por Sandoval Caraveo, María del Carmen, Magaña Medina, Deneb Elí, Surdez Pérez, Edith Georgina
Publicado em 2013-09-01

Breast Cancer in Latinas: Gene Expression, Differential Response to Treatments, and Differential Toxicities in Latinas Compared with Other Population Groups

Por Patel, Tejal A., Colon-Otero, Gerardo, Bueno Hume, Celyne, Copland, John A., Perez, Edith A.
Publicado em 2010

Neural Structures Mediating Expression and Extinction of Platform-Mediated Avoidance

Por Bravo-Rivera, Christian, Roman-Ortiz, Ciorana, Brignoni-Perez, Edith, Sotres-Bayon, Francisco, Quirk, Gregory J.
Publicado em 2014

Long-Term Cardiac Safety Analysis of NCCTG N9831 (Alliance) Adjuvant Trastuzumab Trial

Por Advani, Pooja P., Ballman, Karla V., Dockter, Travis J., Colon-Otero, Gerardo, Perez, Edith A.
Publicado no J Clin Oncol (2016)

p120 catenin induces opposing effects on tumor cell growth depending on E-cadherin expression

Por Soto, Edwin, Yanagisawa, Masahiro, Marlow, Laura A., Copland, John A., Perez, Edith A., Anastasiadis, Panos Z.
Publicado em 2008

Effective Targeting of Estrogen Receptor Negative Breast Cancers with the Protein Kinase D inhibitor CRT0066101

Por Borges, Sahra, Perez, Edith A., Thompson, E. Aubrey, Radisky, Derek C., Geiger, Xochiquetzal J., Storz, Peter
Publicado no Mol Cancer Ther (2015)

Erratum to: Dual HER2 blockade: preclinical and clinical data

Por Patel, Tejal A, Dave, Bhuvanesh, Rodriguez, Angel A, Chang, Jenny C, Perez, Edith A, Colon-Otero, Gerardo
Publicado no Breast Cancer Res (2014)

Dual HER2 blockade: preclinical and clinical data

Por Patel, Tejal A, Dave, Bhuvanesh, Rodriguez, Angel A, Chang, Jenny C, Perez, Edith A, Colon-Otero, Gerardo
Publicado no Breast Cancer Res (2014)

Effect of Body Mass Index (BMI) on Tumor Characteristics and Disease-Free Survival in Patients from the HER2-Positive Adjuvant Trastuzumab Trial N9831

Por Crozier, Jennifer A., Moreno-Aspitia, Alvaro, Ballman, Karla V., Dueck, Amylou C., Pockaj, Barbara A., Perez, Edith A.
Publicado em 2013